Hofseth Biocare ASA's market cap is currently ―. The company's EPS TTM is $-0.023; its P/E ratio is -7.65; Hofseth Biocare ASA is scheduled to report earnings on August 30, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	kr 33.61M	kr 30.22M	kr 25.83M	kr 30.78M	kr 26.08M
Gross Profit	kr 5.98M	kr 5.74M	kr 8.09M	kr 8.70M	kr 5.13M
EBIT	kr -35.43M	kr -32.93M	kr -25.50M	kr -33.57M	kr -32.85M
EBITDA	kr -28.45M	kr -25.22M	kr -17.04M	kr -26.31M	kr -25.45M
Net Income Common Stockholders	kr -38.27M	kr -35.07M	kr -28.38M	kr -35.67M	kr -39.19M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	kr 29.88M	kr 46.22M	kr 5.69M	kr 30.57M	kr 47.21M
Total Assets	kr 411.03M	kr 421.33M	kr 378.87M	kr 397.92M	kr 415.97M
Total Debt	kr 104.17M	kr 106.53M	kr 159.66M	kr 135.60M	kr 139.18M
Net Debt	kr 74.29M	kr 60.31M	kr 153.97M	kr 105.03M	kr 91.97M
Total Liabilities	kr 263.00M	kr 235.38M	kr 300.98M	kr 289.91M	kr 275.60M
Stockholders Equity	kr 148.72M	kr 186.64M	kr 78.58M	kr 108.70M	kr 141.06M
Cash Flow	-
Free Cash Flow	kr 44.08M	kr -45.83M	kr -47.79M	kr -13.40M	kr -25.79M
Operating Cash Flow	kr 46.80M	kr -39.50M	kr -43.63M	kr -8.83M	kr -21.80M
Investing Cash Flow	kr -2.72M	kr -6.33M	kr -4.17M	kr -4.57M	kr -4.18M
Financing Cash Flow	kr -57.87M	kr 86.36M	kr 22.91M	kr -5.95M	kr -9.70M

Currency in NOK

Hofseth Biocare ASA Earnings and Revenue History

Income Statement >

Hofseth Biocare ASA Debt to Assets

Balance Sheet >

Hofseth Biocare ASA Cash Flow

Cash Flow >

Hofseth Biocare ASA Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing